10 min read

What Is a Multi-Omics Data Analysis Platform for R&D?

What Is a Multi-Omics Data Analysis Platform for R&D?

A multi-omics data analysis platform is software that stores, harmonizes, analyzes and shares data from two or more omics layers, such as metagenomics, transcriptomics, proteomics and metabolomics, in one governed environment.

For an R&D organization, the multi-omics platform you choose decides whether each study becomes a reusable asset or another folder of one-off scripts that nobody can rerun. The second outcome has a measurable cost. In a Nature survey of 1,576 researchers, more than 70% had tried and failed to reproduce another scientist's experiments, and more than half had failed to reproduce their own (Baker, Nature, 2016).

Multi-omics research multiplies that risk. Every extra data type adds its own pipeline, file format, preprocessing steps and analyst, so the number of places where a result can quietly break grows with each layer. Choosing a platform therefore starts with one question: which of the five capabilities below will it handle for you, and which will your team still have to build?

 

Book a demo

 

What Is a Multi-Omics Data Analysis Platform?

 

A multi-omics data analysis platform is a single environment where research teams bring in data from multiple omics layers, prepare it to a common standard, run statistics and integration methods on it, and keep the results reusable. The defining feature is a shared data model: every omics layer, biological sample and analysis sits in one place, linked to the same metadata. A folder of separate tools, one per data type, can produce multi-omics data analysis, but it cannot keep the studies connected once the analysts move on.

Vendors use several names for the same category. Multi-omics platform, omics data platform and omics operating system all describe software built for omics data analysis across data types, as opposed to a single-assay tool such as an RNA-seq aligner or a 16S rRNA amplicon pipeline. Scope differs by vendor. Some platforms focus on human genomic and clinical data for precision medicine, some on single-cell and spatial transcriptomics, and others, such as Cosmos-Hub 2.0, on microbiome, metabolomics and related multi-omics research.

 

Which Omics Layers Does a Multi-Omics Platform Handle?

 

A multi-omics platform handles some combination of the omics layers below, and each layer measures biology at a different level, from DNA sequence to small-molecule metabolites. Check which layers a platform accepts as raw data and which only as processed input data, because that decides how much preprocessing your team still does elsewhere.

 

Omics layer

What it measures

Typical input data

Genomics

The DNA sequence of an organism, including genetic variants

Whole genome or exome reads, variant calls

Epigenomics

Chemical modifications to DNA that regulate gene expression

Methylation arrays, bisulfite sequencing

Transcriptomics

The RNA transcripts present in a cell or tissue

RNA-seq counts, single cell and spatial transcriptomics matrices

Proteomics

The proteins expressed in a cell or sample

Mass spectrometry or affinity-based protein data

Metabolomics

Small-molecule metabolites in biological samples

Feature tables from mass spectrometry or NMR

Metagenomics

The genetic material of the microbial community in a sample

Shotgun and 16S/ITS amplicon reads, taxonomic profiles

Metatranscriptomics

The genes a microbial community is actively expressing

Microbial RNA reads or feature tables

 

 

What Is the Difference Between Omics and Multi-Omics?

 

Omics analysis studies one molecular layer at a time, while multi-omics analysis measures several layers on the same set of biological samples and interprets them together. A single-omics study can show that a microbe is more abundant in one group than another. A multi-omics study can show whether that microbe is also expressing different genes and whether the metabolites it produces change, which moves a finding from association toward disease mechanisms.

The Integrative Human Microbiome Project's study of inflammatory bowel disease shows the difference in practice. Researchers followed 132 people for one year and profiled 2,965 stool, biopsy and blood samples, combining microbial taxonomy and function with microbial transcription, metabolite pools such as bile acids and short-chain fatty acids, and host serum antibody levels (Lloyd-Price et al., Nature, 2019). The study identified disruptions across all of those layers during periods of disease activity, a picture of human health and disease that no single layer could have given.

 

Why Do R&D Teams Need a Multi-Omics Platform?

 

R&D teams need a multi-omics platform because multi-omics data analysis breaks down when each data type lives in its own tool, with its own analyst and file format. This often leads to scientific knowledge being scattered across disconnected workflows, one-off analyses and isolated datasets. The result is fragmentation that creates three concrete challenges.

  • Scarce integration skills. In a survey of 704 NSF-funded principal investigators, 89% said they needed training to integrate multiple data types (Barone et al., PLOS Computational Biology, 2017). Every request for integrative analysis queues behind a small group of specialists.
  • Unrepeatable results. A result produced by an unversioned script on one laptop cannot be audited, rerun or defended in a methods section, and the reproducibility figures above show how often that happens.
  • Knowledge that leaves with people. When the scientist who ran an analysis leaves or a project transfers, the parameters and decisions behind it usually leave too. The Cosmos-Hub 2.0 launch material names this operational risk directly: knowledge lost when people leave or projects transfer.

A multi-omics platform earns its cost when the second study runs faster than the first, because the first study's data, pipelines and decisions are still there to build on.

 

The Five Capabilities That Define a Multi-Omics Platform

 

A complete multi-omics platform covers five capabilities: data onboarding and management, harmonization and quality control, statistical analysis, data integration, and knowledge governance. A platform that lacks any one of them pushes that work back onto spreadsheets, personal scripts or email. Use the table below as an evaluation scorecard: put the question in the third column to each vendor, and treat the red flag as a reason to look closer.

 

Capability

What it does

Ask the vendor

Red flag

1. Data onboarding and data management

Accepts raw reads and processed feature tables for each omics layer, linked to sample metadata

Which omics data types can we upload as raw data, and which only as processed tables?

Each data type needs its own project, account or tool

2. Harmonization and quality control

Aligns sample IDs, metadata vocabulary and normalization across layers before analysis

How do you reconcile sample identifiers and metadata labels across layers?

Harmonization is a manual export step outside the platform

3. Statistical analysis

Runs validated statistics and visualizations with visible, adjustable parameters

Can we see and change every parameter, and which method version ran?

Results arrive without a method version or parameter record

4. Data integration

Combines layers through joint models or side-by-side analysis of the same samples

Which integration strategies are built in, such as side-by-side comparison or joint models like MOFA, and do they run on matched samples across every layer?

Integration means exporting each layer to R and combining them by hand

5. Knowledge and governance

Version-controls studies, pipelines and shared analysis frameworks so every team can reuse them, with permissions and a full audit trail

Are our pipelines and analysis frameworks version-controlled and reusable across teams, and what happens to them when their owner leaves?

Pipelines live in personal scripts with no version history, and sharing works by downloading files with no audit trail or SSO



Most tools on the market are strongest in one or two of these capabilities. Cloud infrastructure tends to lead on data management and security, open-source method libraries on integration, and no-code analysis apps on statistics through an intuitive interface. The fifth capability, knowledge governance, is the one most often left to the customer, and it is the one that decides whether multi-omics research compounds over time or restarts with every project.

 

 

How Does Multi-Omics Data Integration Work?

 

Multi-omics data integration combines measurements from different omics layers so that patterns shared across layers become visible, and published reviews group the methods into five strategies: early, mixed, intermediate, late and hierarchical integration (Picard et al., Computational and Structural Biotechnology Journal, 2021). The strategy you choose depends on your experimental design, your sample size and the question you need answered.

  • Early integration concatenates every layer into one large table before analysis. It is simple, but the largest layer can dominate and the table holds far more features than samples.
  • Mixed integration turns each layer into a simpler representation first, such as a similarity network or kernel, and then combines those representations.
  • Intermediate integration learns one joint representation of all layers at once, such as the latent factors in Multi-Omics Factor Analysis (MOFA).
  • Late integration analyzes each layer separately and combines the results or predictions at the end, which keeps each layer's own statistics intact.
  • Hierarchical integration builds known regulatory relationships between layers, such as DNA to RNA to protein, into the model itself.

 

Why Matched Samples Matter for Integrating Multi-Omics Data

 

Matched multi-omics data comes from the same set of biological samples measured on every layer, while unmatched data comes from different samples or cohorts. Joint models such as MOFA need samples shared across layers to link them, so the experimental design decides which integration methods are open to you before any data is generated. Plan which samples go to which assay at the design stage, and record a single sample ID that every layer uses.

 

Which Tools Do Bioinformaticians Use for Integration?

 

Bioinformaticians most often integrate multi-omics data with established open-source methods such as MOFA, mixOmics, iClusterPlus and similarity network fusion. MOFA identifies hidden factors that explain variation across multiple data types (Argelaguet et al., Molecular Systems Biology, 2018). mixOmics is an R package of multivariate methods for feature selection and multiple data integration, widely used for classification and biomarker discovery (Rohart et al., PLOS Computational Biology, 2017). iClusterPlus groups samples into disease subtypes from integrated genomic data.

A platform's job is not to replace these methods. Its job is to feed them clean, harmonized, matched input data and to keep their outputs versioned and reusable. In practice the most workable split is simple: scientists run standard per-layer statistics and side-by-side comparisons themselves, and bioinformaticians build joint integration models once and deploy them as version-controlled frameworks the whole team can rerun.

 

Book a demo

 

What Is Multi-Omics Data Analysis Used For?

 

Multi-omics data analysis is used for four main R&D goals: biomarker prediction, patient stratification, drug discovery and explaining disease mechanisms. Each goal depends on reading omics profiles across multiple levels of biology rather than one.

  • Biomarker prediction: combining genomic, transcriptomic and protein data with machine learning to find markers that separate disease phenotypes more reliably than any single layer.
  • Patient stratification: splitting patients into subgroups based on shared omics profiles, so trials and treatments target the people most likely to respond. The Cancer Genome Atlas, run by the National Cancer Institute, molecularly characterized over 20,000 primary cancer and matched normal samples across 33 cancer types and generated over 2.5 petabytes of genomic, epigenomic, transcriptomic and proteomic data, much of it used for exactly this kind of subtyping (National Cancer Institute).
  • Drug discovery: linking gene expression, protein expression and pathway data to identify therapeutic targets, a core use for pharmaceutical companies and the life sciences industry.
  • Disease and microbiome mechanisms: connecting what a microbial community contains, what it expresses and which metabolites it produces, as in the inflammatory bowel disease study above. Consumer health, nutrition and personal care research teams use this approach as well as clinical laboratories and academic institutions.

 

Four Types of Omics Data Platform Compared

 

Omics data platforms fall into four types: cloud research environments, code-based methods and workflow tools, no-code analysis apps, and centralized omics operating systems. We grouped them by what each is built to do, using vendors' own product descriptions and published reviews of integration methods. The type matters more than the brand, because it decides which of the five capabilities your team will still have to build or check.

 

Platform type

Examples

Strongest capability

Check before choosing

Best fit

Cloud research environment or data platform

DNAnexus, Databricks, AWS with internal pipelines

Data management, scale and secure collaboration

Who builds analysis interfaces for non-coders, and how studies are captured for reuse

Large genomic and clinical data programs with in-house engineering

Code-based methods and workflow tools

MOFA, mixOmics, QIIME 2, Galaxy, RStudio

Integration methods and flexibility

Who maintains scripts, permissions and metadata standards

Bioinformatics teams developing new methods

No-code analysis app

Omics Playground, One Codex

Fast exploration for scientists

Which data types are covered, and how studies are shared and governed across teams

Teams exploring one main data type

Centralized omics operating system

Cosmos-Hub 2.0

Knowledge governance plus no-code statistics

Whether your main data types are supported

R&D organizations running microbiome and multi-omics studies across several teams



How Cosmos-Hub 2.0 Works as a Multi-Omics Platform

 

Cosmos-Hub 2.0 is Cmbio’s centralized omics operating system: a cloud multi-omics platform built to turn every omics study into a reusable scientific asset, with analyses that scientists can run without writing code. It expands the original Cosmos-Hub microbiome profiling platform to cover the full data-to-decision workflow. Mapped against the five capabilities in the scorecard above, the platform provides the following.

  1. Data onboarding and data management: raw shotgun metagenomic and 16S/ITS amplicon reads run through validated profiling pipelines (CHAMP, Kepler, DADA2-based short-read amplicon profiling and EMU-based long-read amplicon profiling), and custom feature tables upload directly for metagenomics, metatranscriptomics, metabolomics and proteomics. All of it is stored in one central, secure platform rather than in a separate tool for each data type.
  2. Harmonization and quality control: guided multi-omics onboarding and a harmonization layer bring each data type into one study structure, so layers share samples and metadata from the start.
  3. Statistical analysis: the Analysis Studio brings together a library of standard statistical methods for omics data, each verified by Cmbio. It supports group comparisons and exact tests with multiple-testing correction (Mann-Whitney U, Kruskal-Wallis with Dunn’s post-hoc tests, and Fisher’s, Barnard’s and Boschloo’s exact tests), diversity and ordination analyses (rarefaction curves, and t-SNE, MDS and UMAP ordinations with PERMANOVA), multivariable association modeling (MaAsLin3), machine-learning classifiers and regression models (Random Forest, logistic regression, SVM, gradient boosting, and regression for continuous outcomes), and metabolomics secondary analysis. Scientists can change parameters and visualizations through a form, without code. See the full statistics toolbox.
  4. Data integration: Cosmos-Hub 2.0 is designed with microbiome multi-omics in mind. The ’omics layers of a study share one study structure, linked to the same samples and metadata. Scientists can import microbial taxonomic profiles, metatranscriptomic functional profiles and metabolomics results and compare them on the same platform, without exporting files or reconciling sample IDs by hand. For custom projects that require next-level ’omics integration, Cmbio also runs integrative systems biology and multi-omics services.
  5. Knowledge and governance: pipelines, analysis frameworks and studies are version-controlled and reusable across teams, so a study’s methods and decisions stay in place when its owner leaves. Enterprise workspaces add user roles and granular permissions, with SSO, MFA, GDPR-aligned permissions and full provenance tracking on AWS. The licensed Cmbio Atlas, a reference dataset of 150,000+ samples, supplies comparable samples and cohorts for new studies to build on. Visit the study and data management and enterprise solutions pages to learn more.

Cosmos-Hub has 1,000+ users in 30+ countries, who have profiled 600,000+ samples and run 170,000+ analyses on the platform. Nezar Al-Hebshi, PhD, at Temple University, puts the practical gain simply: the ease of data handling and the range of tools, including LEfSe and MaAsLin3, cut the time he needs to run analyses on his own.

Cosmos-Hub 2.0 is built for microbiome-centered multi-omics. Teams whose main data is human germline genomics, single cell multi-omics or spatial transcriptomics should confirm their data types are covered before shortlisting it, as they should with any platform.

 

Your Next Step

 

List the omics data types your teams generated in the last 12 months and who analyzed each one. Then score your current setup against the five capabilities in the scorecard. Any capability that lives in a spreadsheet, a personal script or one person's memory is where your next multi-omics study will lose time. To see how Cosmos-Hub 2.0 covers each capability on your own data, book a demo.

Book a demo

 

 

Questions R&D Teams Ask About Multi-Omics Platforms

 

What are the four main omics?

 

The four main omics are genomics, transcriptomics, proteomics and metabolomics, which measure DNA, RNA, proteins and metabolites respectively. Many multi-omics platforms also handle epigenomics and microbiome layers such as metagenomics and metatranscriptomics.

 

Is a multi-omics platform the same as a LIMS?

 

A multi-omics platform is not the same as a LIMS. A laboratory information management system tracks samples and lab workflows, while a multi-omics platform analyzes the biological data those samples produce. The two connect through shared sample IDs and metadata.

 

Do you still need bioinformaticians with a multi-omics platform?

 

Bioinformaticians are still needed with a multi-omics platform, for experimental design, quality review, new methods and joint integration models. The platform takes routine reruns and figure requests off their desks, so their time goes to the work only they can do.

 

What is the best multi-omics platform?

 

The best multi-omics platform is the one that supports your omics data types and covers all five capabilities in the scorecard above for the people who will use it. Test any shortlisted platform on your own data, not a vendor demo dataset.

No-Code Bioinformatics: Run Your Own Omics Analysis

No-Code Bioinformatics: Run Your Own Omics Analysis

Which omics analyses a bench scientist can run without code, a five-point pre-flight checklist, and when to bring in a bioinformatician.

Read More
Introducing Cosmos-Hub 2.0: What’s New in the Omics Operating System

Introducing Cosmos-Hub 2.0: What’s New in the Omics Operating System

Introducing Cosmos-Hub 2.0: centralized omics operating system for multi-omics research, offering 40+ tools and enterprise collaboration

Read More
Enterprise Collaboration Tools for Omics R&D: What Research Teams Actually Need

Enterprise Collaboration Tools for Omics R&D: What Research Teams Actually Need

Cosmos-Hub 2.0: Enterprise-grade omics collaboration tools. Improve R&D productivity with governed data and shared workspaces.

Read More